Aronex regulatory update

The University of Texas M.D. Anderson Cancer Center received European Patent No. 567,582b1 covering a method of producing Nystatin, ARNX's liposomal product to treat serious fungal infections. ARNX has exclusive worldwide rights to the patent. ...